Implications of False Positive Serology of Toxoplasma gondii in a Pre-transplant Patient

被引:6
|
作者
Beal, Stacy [1 ]
Racsa, Lori [1 ]
Alatoom, Adnan [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源
LABMEDICINE | 2014年 / 45卷 / 01期
关键词
Toxoplasma gondii; false positive IgM; serology;
D O I
10.1309/LMQIB0BPOJ96WGCU
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patient: A 21-year-old white male with cystic fibrosis. Chief Complaint: Pre-transplant workup in preparation for bilateral lung transplant. Past Medical History: Cystic fibrosis diagnosed at age 3, onset of insulin-dependent diabetes around age 20, and multiple hospitalizations for pulmonary and gastrointestinal complications. Family and Social History: The patient lives with his father and stepmother, has a pet bearded dragon, and has multiple tattoos and piercings. His stepmother has a cat, but he does not clean the litter box. Principal Laboratory Findings: The pre-transplant workup included several tests for infectious diseases, tests of organ function, radiology studies, and markers of malignancy. The only significant finding was a positive Toxoplasma gondii(T gondii) IgM titer (>= 1:40) (reference values for IgM: negative; <1:40, positive; >= 1:40) and IgG (1:2048) (reference values for IgG: negative; <1:16, equivocal;>= 1:16 - <1:256, positive; >= 1:256). Testing was done by indirect immunofluorescence assay (IFA) in April 2012 in our hospital laboratory. The patient was treated with sulfadiazine, leucovorin, and pyrimethamine. Three months later (July), he returned for follow-up testing. Real-time polymerase chain reaction (PCR) for T. gondii DNA performed by a reference laboratory was negative. One month later (August), Toxoplasma serology was performed by enzyme-linked immunosorbent assay (ELISA) by a different reference laboratory and showed an elevated IgM of 0.95 IU/mL (reference values: negative; <0.55 IU/mL, equivocal; >= 0.55-<0.65 IU/mL, positive; >= 0.65 IU/mL) and a normal level of IgG (<4 IU/mL). At this time, PCR was repeated and was negative. An additional month later (September), the patient's serology studies were performed at a third reference laboratory and showed an elevated IgM of 1.32 IU/mL (reference values: negative; 0.89, equivocal; 0.90 - 1.09, positive; >1.10) and a normal IgG.
引用
收藏
页码:56 / 58
页数:3
相关论文
共 50 条
  • [41] Predicting a kidney transplant patient's pre-transplant functional status based on information from waitlist registration
    Mark, Ethan
    Goldsman, David
    Gurbaxani, Brian
    Keskinocak, Pinar
    Sokol, Joel
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] Predicting a kidney transplant patient’s pre-transplant functional status based on information from waitlist registration
    Ethan Mark
    David Goldsman
    Brian Gurbaxani
    Pinar Keskinocak
    Joel Sokol
    Scientific Reports, 13
  • [43] Impact of Pre-Transplant Coronary Revascularization on Patient and Graft Survival after Deceased Donor Renal Transplant.
    Klein, Christina
    Leverson, Glen
    Voss, Barbara
    Neidlinger, Nikole
    Mezrich, Joshua
    Pirsch, John
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 427 - 427
  • [44] The Grade of Pre-Transplant Portal Vein Thrombosis in Liver Transplant Recipients Impacts Graft and Patient Survival.
    Safwan, M.
    Sobolic, M.
    Nagai, S.
    Schilke, R.
    Collins, K.
    Yoshida, A.
    Abouljoud, M.
    Rizzari, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 975 - 976
  • [45] Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen
    Ahn, Hyung Joon
    Kim, Myoung Soo
    Kim, Yu Seun
    Kim, Soon Il
    Huh, Kyu Ha
    Ju, Man Ki
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1655 - 1663
  • [46] Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients
    Son, Bong Soo
    Lee, Hyun Ji
    Cho, Woo Hyun
    So, Min Wook
    Park, Jong Myung
    Yeo, Hye Ju
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [47] Prospective Post-Transplant DSA Monitoring in Kidney Transplant Recipients With Pre-Transplant DSA and a Positive Crossmatch Treated With IVIG/Rituximab
    Shaffer, D.
    Feurer, I.
    Crowe, D.
    Heidi, S.
    TRANSPLANTATION, 2014, 98 : 104 - 104
  • [48] False-Positive HIV and HCV Serology Due to Nonspecific Antibody Binding in a Patient With Polyclonal Hypergammaglobulinemia
    Pimentel, Jason D.
    Luzzi, Veronica
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 505 - 505
  • [49] Prospective Post-Transplant DSA Monitoring in Kidney Transplant Recipients With Pre-Transplant DSA and a Positive Crossmatch Treated With IVIG/Rituximab
    Shaffer, D.
    Feurer, I.
    Crowe, D.
    Heidi, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 104 - 104
  • [50] Implications of Pre-Transplant (tx) COVID-19 on SOT or HCT: A Multicenter Study.
    Haidar, G.
    Hughes-Kramer, K.
    Alonso, C.
    Hand, J.
    Blodget, E.
    Srinivasa, V.
    Aslam, S.
    Hassouna, H.
    Lawson, C.
    Malinis, M.
    Anjan, S.
    Lease, E.
    Al-Obaidi, M.
    Vergidis, P.
    Husson, J.
    van Duin, D.
    Avery, R.
    Downes, K.
    Heldman, M. R.
    Nelson, J.
    Pouch, S.
    Chuang, S.
    Kao, C.
    Estabrook, M.
    Alconchel, F.
    Mazumber, S.
    Samanta, P.
    Wagener, M.
    Singh, N.
    Silveira, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1057 - 1058